The PPC team added a great value to our work on
sputum and mucus rheology thanks to their
high-level technology, their scientific rigor and their
enthusiasm. They are an example of how research
on translationnal and precision medicine should
always be done.

– Dr. Jeremy Charriot
University of Montpellier, PhyMedExp INSERMU1046

The Clinical Proteomic Platform (PPC) directed by Prof. Christophe Hirtz is a close partner in different international projects that we lead at the University Medical Center of Montpellier, France. There is no
doubt that this expertise in proteomics is a key to understand the biology of the metastatic cascade in cancer patients.

– Dr. Catherine Alix-Panabières
Associate Professor at the Faculty of Medicine of the University of Montpellier, Director of the Laboratory Rare Circulating Human Cells (LCCRH) at CHU Montpellier

The PPC is a crucial scientific and technical partner
allowing translational research. We have been
working together for several years in parallel with
their continuous technological advancements and
refinements, allowing for state-of-the-art, detailed
and sensitive analyses of biological samples.

–  Luis E. Cortes
Marie Skłodowska-Curie Fellow at the University Medical Center of Montpellier

The Clinical Proteomic Platform (PPC) under the
auspices of Prof. Christophe Hirtz has been an instrumental part of our international research
program. This cutting-edge technology has provided unique insight into the mechanisms that contribute to maintaining structural integrity of the neurovascular
unit, highlighting the fundamental importance of
oxygen and gravity in ‘extreme experiments’
supported by the European Space Agency.

– Pr. Damien Bailey
Director of the Neurovascular Research Laboratory, Faculty of Life Sciences and Education, University of South Wale